All In MedTech

FDA Clearance Tracker · P080030-S005

GLAUKOS TRABECULAR MICRO BYPASS STENT MODEL GTS100R/L

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 5, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 5, 2013

Approved

Time to decision

228 days

Received Jul 20, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080030-S005
Device name
GLAUKOS TRABECULAR MICRO BYPASS STENT MODEL GTS100R/L
Applicant location
Laguna Hills, CA
Received
Jul 20, 2012
Decided
Mar 5, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P080030

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OGO

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Glaukos Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.